References
O’Shaughnessy MM, Montez-Rath ME, Lafayette RA, Winkelmayer WC. Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015. https://doi.org/10.2215/CJN.11261114.
Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017. https://doi.org/10.1016/j.kint.2017.03.015.
Nozu K, Nakanishi K, Abe Y, Udagawa T, Okada S, Okamoto T, et al. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019. https://doi.org/10.1007/s10157-018-1629-4.
Browne G, Brown PA, Tomson CR, Fleming S, Allen A, Herriot R, et al. Retransplantation in Alport post-transplant anti-GBM disease. Kidney Int. 2004. https://doi.org/10.1111/j.1523-1755.2004.00428.x.
Acknowledgements
We thank Susan Furness, PhD, from Edanz Group (https://jp.edanz.com/english-editing-c) for editing the English text of a draft of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written informed consent was obtained from this patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ueki, K., Tsuchimoto, A., Matsukuma, Y. et al. A case of end-stage kidney disease due to Alport syndrome diagnosed by skin biopsy after review of a renal biopsy 12 years ago. CEN Case Rep (2024). https://doi.org/10.1007/s13730-024-00887-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13730-024-00887-x